• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks.LY164846的体外抗菌活性测试，包括使用30微克纸片的纸片扩散药敏试验。
Antimicrob Agents Chemother. 1986 Mar;29(3):530-4. doi: 10.1128/AAC.29.3.530.
2
Antimicrobial activity of LY164846, a new oral cephalosporin, and recommendations for disk diffusion tests.新型口服头孢菌素LY164846的抗菌活性及纸片扩散法试验建议
Diagn Microbiol Infect Dis. 1987 Jan;6(1):41-8. doi: 10.1016/0732-8893(87)90112-x.
3
In vitro activity of an orally administered cephalosporin, LY164846, against potentially pathogenic respiratory and dermal bacterial isolates.口服头孢菌素LY164846对潜在致病性呼吸道和皮肤细菌分离株的体外活性。
Antimicrob Agents Chemother. 1986 Apr;29(4):560-4. doi: 10.1128/AAC.29.4.560.
4
Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.新型口服头孢菌素头孢布烯（7432-S；SCH 39720）的抗菌活性、抗菌谱及纸片扩散法药敏试验建议
Antimicrob Agents Chemother. 1988 Oct;32(10):1576-82. doi: 10.1128/AAC.32.10.1576.
5
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.头孢替坦，一种新型头孢霉素：与其他头孢菌素的体外抗菌活性比较、β-内酰胺酶稳定性及纸片扩散法检测的初步建议
Antimicrob Agents Chemother. 1982 Nov;22(5):859-77. doi: 10.1128/AAC.22.5.859.
6
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).新型头孢菌素酯U-76,252（CS-807）的活性代谢产物U-76,253A（R-3746）的抗菌活性及纸片扩散法药敏试验
Antimicrob Agents Chemother. 1988 Apr;32(4):443-9. doi: 10.1128/AAC.32.4.443.
7
In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.新型口服头孢菌素U-76,252（CS-807）的体外活性
Antimicrob Agents Chemother. 1988 Jul;32(7):1082-5. doi: 10.1128/AAC.32.7.1082.
8
Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):677-85. doi: 10.1007/BF01964272.
9
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Diagn Microbiol Infect Dis. 1987 Mar;6(3):185-92. doi: 10.1016/0732-8893(87)90011-3.
10
Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.新型头孢菌素酯Ro 41-3399的活性代谢产物Ro 40-6890的抗菌活性及纸片扩散药敏试验
Antimicrob Agents Chemother. 1993 Apr;37(4):893-5. doi: 10.1128/AAC.37.4.893.

引用本文的文献

1
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.新型口服头孢菌素（Ro 15-8075）的活性代谢产物Ro 15-8074对7775株近期临床分离菌株的抗菌活性。
Antimicrob Agents Chemother. 1986 Dec;30(6):961-3. doi: 10.1128/AAC.30.6.961.

本文引用的文献

1
Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.头孢氨苄和头孢克洛与头孢噻吩及新型头孢菌素抗菌谱的比较：对药敏试验类别代表性概念的重新评估。
J Clin Microbiol. 1983 Jun;17(6):1156-8. doi: 10.1128/jcm.17.6.1156-1158.1983.
2
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.新型口服活性头孢烯抗生素FK 027的体外和体内抗菌特性
Antimicrob Agents Chemother. 1984 Jan;25(1):98-104. doi: 10.1128/AAC.25.1.98.
3
The antimicrobial activity of cephalexin against old and new pathogens.
Postgrad Med J. 1983;59 Suppl 5:9-15.
4
Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.厌氧菌药敏试验：统计学与临床考量
J Infect Dis. 1974 Dec;130(6):588-94. doi: 10.1093/infdis/130.6.588.
5
Cefadroxil, a new broad-spectrum cephalosporin.头孢羟氨苄，一种新型广谱头孢菌素。
Antimicrob Agents Chemother. 1977 Feb;11(2):324-30. doi: 10.1128/AAC.11.2.324.
6
Summary of laboratory studies on the antibacterial activity of cefaclor.头孢克洛抗菌活性的实验室研究总结。
Postgrad Med J. 1979;55 Suppl 4:22-9.

LY164846的体外抗菌活性测试，包括使用30微克纸片的纸片扩散药敏试验。

LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks.

作者信息

Jones R N, Baker C, Barry A L, Fuchs P C

出版信息

Antimicrob Agents Chemother. 1986 Mar;29(3):530-4. doi: 10.1128/AAC.29.3.530.

DOI:10.1128/AAC.29.3.530
PMID:3755018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC180430/
Abstract

A new oral cephalosporin, LY164846 (Eli Lilly & Co., Indianapolis, Ind.), was found to have a unique antimicrobial spectrum confined to methicillin-susceptible Staphylococcus spp., streptococci (except Enterococcus spp.), Haemophilus influenzae, Branhamella catarrhalis, and some anaerobes. Cephalothin in vitro tests (30-microgram disks or dilution) can represent LY164846 for laboratory testing if comparable interpretive breakpoints are applied to strains within the spectrum of LY164846. Organisms not inhibited by LY164846 (MICs greater than or equal to 32 micrograms/ml) were members of the family Enterobacteriaceae, Pseudomonas spp., Acinetobacter spp., enterococci, and some strains of Staphylococcus haemolyticus and of the Bacteroides fragilis group.

摘要

一种新型口服头孢菌素LY164846（礼来公司，印第安纳波利斯，印第安纳州）被发现具有独特的抗菌谱，仅限于对甲氧西林敏感的葡萄球菌属、链球菌（肠球菌属除外）、流感嗜血杆菌、卡他布兰汉菌以及一些厌氧菌。如果将可比的解释性断点应用于LY164846谱内的菌株，头孢噻吩体外试验（30微克纸片或稀释法）可用于实验室检测来代表LY164846。未被LY164846抑制的微生物（最低抑菌浓度大于或等于32微克/毫升）包括肠杆菌科、假单胞菌属、不动杆菌属、肠球菌以及一些溶血葡萄球菌菌株和脆弱拟杆菌群菌株。